4//SEC Filing
Thye Dirk 4
Accession 0001209191-23-045235
CIK 0001662774other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:23 PM ET
Size
5.1 KB
Accession
0001209191-23-045235
Insider Transaction Report
Form 4
Thye Dirk
DirectorCEO and CMO
Transactions
- Purchase
Common Stock
2023-08-08$1.24/sh+80,000$99,200→ 360,911 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001638945
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 6:23 PM ET
- Size
- 5.1 KB